These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 781133)

  • 1. Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers.
    Yoshida T; Kuratsuji T; Takada A; Takada Y; Minowada J; Cohen S
    J Immunol; 1976 Aug; 117(2):548-54. PubMed ID: 781133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms.
    Ward PA; Dvorak HF; Cohen S; Yoshida T; Data R; Selvaggio SS
    J Immunol; 1975 May; 114(5):1523-31. PubMed ID: 1091704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
    Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of B cell MIF production by T cells and soluble T cell-derived factors.
    Cohen S; Yoshida T
    J Immunol; 1977 Aug; 119(2):719-21. PubMed ID: 328780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of lymphokine-like factors (cytokines) by simian virus 40-infected and simian virus 40-transformed cells.
    Bigazzi PE; Yoshida T; Ward PA; Cohen S
    Am J Pathol; 1975 Jul; 80(1):69-78. PubMed ID: 168779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
    Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
    Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterization of chemotatic lymphokines produced by human T and B lymphocytes.
    Altman LC; Chassy B; Mackler BF
    J Immunol; 1975 Jul; 115(1):18-21. PubMed ID: 1097502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to guinea pig lymphokines. IV. Suppression of the mixed leukocyte culture reaction by anti-lymphokine globulin.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Nov; 117(5 Pt.2):1824-31. PubMed ID: 136471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of macrophages in the production of lymphokines by T and B lymphocytes.
    Wahl SM; Wilton JM; Rosenstreich DL; Oppenheim JJ
    J Immunol; 1975 Apr; 114(4):1296-301. PubMed ID: 1090672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cell lines secreting lymphokines. II. BCGF production by a T hybridoma and B cell lines.
    Gozes Y; Epstein N; Halmann M; Bino T; Rosenberg H; Kobiler D
    Dev Biol Stand; 1987; 66():447-55. PubMed ID: 3495463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cell-mediated immunity in the induction of inflammatory responses. Parke-Davis Award Lecture, 1977.
    Cohen S
    Am J Pathol; 1977 Sep; 88(3):502-28. PubMed ID: 329682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elaboration of a small molecular weight cytostatic factor by lymphoblastoid lines and activated lymphocytes.
    Antonia SJ; Cohen S; Cohen MC
    Lymphokine Res; 1986; 5(4):301-12. PubMed ID: 3491253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators in culture filtrates of Escherichia coli.
    Yoshida T; Cohen S; Bigazzi PE; Kurasuji T; Amsden A
    Am J Pathol; 1975 Nov; 81(2):389-400. PubMed ID: 1103632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).
    Weisbart RH; Billing R
    Immunology; 1980 Apr; 39(4):577-82. PubMed ID: 6991400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil migration-inhibition activity produced by a unique T lymphoblast cell line.
    Weisbart RH; Billing R; Golde DW
    J Lab Clin Med; 1979 Apr; 93(4):622-6. PubMed ID: 311803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine production by C3b-stimulated B cells.
    Sandberg AL; Wahl SM; Mergenhagen SE
    J Immunol; 1975 Jul; 115(1):139-44. PubMed ID: 1080163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization: effects on cutaneous and peritoneal manifestations of delayed hypersensitivity in relation to lymphokine production.
    Sonozaki H; Papermaster V; Yoshida T; Cohen S
    J Immunol; 1975 Dec; 115(6):1657-61. PubMed ID: 1102607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.